Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Leukemia ; 22(10): 1917-24, 2008 Oct.
Article in English | MEDLINE | ID: mdl-18615101

ABSTRACT

Gene expression profiles have been associated with clinical outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with anthracycline-containing chemotherapy. Using Affymetrix HU133A microarrays, we analyzed the lymphoma transcriptional profile of 30 patients treated with CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone) and 23 patients treated with rituximab (R)-CHOP in the Groupe d'Etude des Lymphomes de l'Adulte clinical centers. We used this data set to select transcripts showing an association with progression-free survival in all patients or showing a differential effect in the two treatment groups. We performed real-time quantitative reverse transcription-PCR in the 23 R-CHOP samples of the screening set and an additional 44 R-CHOP samples set to evaluate the prognostic significance of these transcripts. In these 67 patients, the level of expression of 16 genes and the cell-of-origin classification were significantly associated with overall survival, independently of the International Prognostic Index. A multivariate model comprising four genes of the cell-of-origin signature (LMO2, MME, LPP and FOXP1) and two genes related to immune response, identified for their differential effects in R-CHOP patients (APOBEC3G and RAB33A), demonstrated a high predictive efficiency in this set of patients, suggesting that both features affect outcome in DLBCL patients receiving immunochemotherapy.


Subject(s)
Antibodies, Monoclonal/administration & dosage , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Gene Expression Profiling , Lymphoma, Large B-Cell, Diffuse/drug therapy , APOBEC-3G Deaminase , Adaptor Proteins, Signal Transducing , Aged , Aged, 80 and over , Antibodies, Monoclonal, Murine-Derived , Cyclophosphamide/administration & dosage , Cytidine Deaminase/genetics , Cytoskeletal Proteins/genetics , DNA-Binding Proteins/genetics , Doxorubicin/administration & dosage , Female , Forkhead Transcription Factors/genetics , Humans , LIM Domain Proteins , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/immunology , Lymphoma, Large B-Cell, Diffuse/mortality , Male , Metalloproteins/genetics , Middle Aged , Multivariate Analysis , Prednisone/administration & dosage , Proto-Oncogene Proteins , Repressor Proteins/genetics , Reverse Transcriptase Polymerase Chain Reaction , Rituximab , Vincristine/administration & dosage , rab GTP-Binding Proteins/genetics
2.
Eur Ann Allergy Clin Immunol ; 38(4): 124-5, 2006 Apr.
Article in English | MEDLINE | ID: mdl-16805418

ABSTRACT

A case of collagenous colitis in a young man treated by isotretinoïn raises the hypothesis of an isotretinoïn inducedcess on the oossible account of atoov and auto-immunity in the family.


Subject(s)
Colitis, Collagenous/chemically induced , Colitis, Collagenous/pathology , Isotretinoin/adverse effects , Acne Vulgaris/drug therapy , Adult , Antibodies, Antinuclear/blood , Autoimmunity , Colitis, Collagenous/immunology , Diagnosis, Differential , Diarrhea/chemically induced , Food Hypersensitivity/pathology , Humans , Male
3.
Presse Med ; 31(22): 1024-6, 2002 Jun 22.
Article in French | MEDLINE | ID: mdl-12148256

ABSTRACT

INTRODUCTION: Granulocyte sarcoma (GS), also known as chloroma, is a localized malignant tumor composed of myeloid cells, the diagnosis of which is difficult. The pancreatic location and recurrence, aside from any context of malignant hemopathy, are exceptional. OBSERVATION: A 31-year-old woman developed an isolated and recurrent granulocyte sarcoma of the pancreas, without any context of a malignant hemopathy. The diagnosis retained on extemporaneous examination was an adenocarcinoma of the pancreas, because of the non-specific necrotic nature of the tumor. The immuno-histochemical exploration corrected the diagnosis. Despite local surgery, an isolated tumor recurred 6 months later. This relapse was treated with radiotherapy followed by heavy chemotherapy, identical to that applied in acute myeloblastic leukemia (AML). Ten months later, remission was stable and complete. COMMENTS: Isolated granulocyte sarcomas located in the pancreas are exceptional and have often led to initial erroneous diagnosis. Immuno-histochemical methods are essential in order to obtain correct diagnosis. Despite the localized nature of the tumor, intensive AML-type chemotherapy is necessary.


Subject(s)
Adenocarcinoma/pathology , Neoplasm Recurrence, Local , Pancreatic Neoplasms/pathology , Sarcoma, Myeloid/pathology , Adenocarcinoma/radiotherapy , Adenocarcinoma/surgery , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Combined Modality Therapy , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Pancreatic Neoplasms/radiotherapy , Pancreatic Neoplasms/surgery , Radiotherapy , Sarcoma, Myeloid/radiotherapy , Sarcoma, Myeloid/surgery
4.
Ann Oncol ; 13(7): 1108-15, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12176791

ABSTRACT

BACKGROUND: p53 alterations have been associated with a poor prognosis in aggressive B-cell lymphoma. We investigated the clinical relevance of p53 status in diffuse large B-cell lymphoma (DLBCL), focusing on patients who belong to lower risk groups of the international prognostic index and were uniformly treated. We aimed to determine whether this biological marker could identify among such patients those with a pejorative outcome who could benefit from a distinct therapeutic approach. PATIENTS AND METHODS: We studied 69 patients presenting with no, one (low-risk, n = 40) or two (low-intermediate risk, n = 29) risk factors treated with an anthracyclin-containing induction regimen. p53 exons 5-8 mutations were screened for using denaturing gradient gel electrophoresis and confirmed by direct sequencing. Immunohistochemical detection of p53 protein and of its downstream target p21 were also evaluated in 60 of 69 cases. RESULTS: p53 mutations were detected in 16 of 69 (23%) lymphoma samples. The presence of a p53 gene mutation affected survival (P = 0.01), with a 6-year survival rate estimated to be 44% in mutated patients, compared with 79% in non-mutated ones. Using a stepwise Cox model, p53 mutation constituted the only parameter affecting survival (relative risk = 2.7, P = 0.03). A p53+/p21- immunohistochemical pattern (n = 15), suggestive of a disrupted p53 function, strongly correlated with p53 gene status and was associated with a lower 6-year survival rate when compared with a p53(-) or p53+/p21+ phenotype (47% versus 74%, P = 0.05). CONCLUSIONS: p53 alterations constitute a pejorative biological indicator able to discriminate among clinically defined lower risk patients with DLBCL.


Subject(s)
Biomarkers, Tumor/analysis , Genes, p53/genetics , Lymphoma, B-Cell/genetics , Lymphoma, B-Cell/mortality , Lymphoma, Large B-Cell, Diffuse/genetics , Lymphoma, Large B-Cell, Diffuse/mortality , Mutation , Adult , Aged , Analysis of Variance , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Base Sequence , Cohort Studies , Female , Humans , Lymphoma, B-Cell/drug therapy , Lymphoma, B-Cell/pathology , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse/pathology , Male , Middle Aged , Molecular Sequence Data , Polymerase Chain Reaction , Probability , Prognosis , Proportional Hazards Models , Prospective Studies , Risk Assessment , Sensitivity and Specificity , Survival Analysis , Treatment Outcome
6.
Ann Pathol ; 21(1): 29-47, 2001 Feb.
Article in French | MEDLINE | ID: mdl-11223558

ABSTRACT

This review deals with the general principles and problems of formaldehyde fixation. After a short description of 1) formaldehyde methods of production, 2) chemical properties of formaldehyde solution, and 3) kinetic of formaldehyde binding in tissue, formaldehyde reactivity with the tissue biopolymers, proteins and cucleic acids mainly, are described. How formaldehyde fixation of tissues adversely affects the reactivity of cellular proteins with their respective specific antibody and the ways the most commonly used retrieval techniques in immunohistochemistry act are, thereafter, discussed. Finally, concerns that need to be dealt with when formalin-fixed specimens are used for genomic analysis and studies of DNA expression are highlighted.


Subject(s)
Fixatives , Formaldehyde , DNA/analysis , Formaldehyde/adverse effects , Formaldehyde/chemistry , Humans , Immunohistochemistry , Kinetics , Lipids/analysis , Microscopy, Electron , Molecular Biology , Oxidation-Reduction , Solutions
7.
Clin Lab Haematol ; 22(5): 297-301, 2000 Oct.
Article in English | MEDLINE | ID: mdl-11122273

ABSTRACT

The history of a 28-year-old woman with anaplastic large cell lymphoma (ALCL) in the first trimester of her pregnancy is reported. Investigations allowed to diagnose a T-cell CD30 positive ALCL, which appearance is rare during pregnancy. Moreover, the atypical lymphoid cells were found in the peripheral blood and were predominantly small to medium sized with nuclear irregularities and cytoplasmic azurophilic granules, which allowed the hypothesis of leukaemic presentation of a small cell variant ALCL. A variant of the t(2:5)(p23:q35) was found [del(2)(p22)]. The patient died shortly after diagnosis.


Subject(s)
Lymphoma, Large-Cell, Anaplastic/pathology , Pregnancy Complications, Neoplastic/pathology , Adult , Chromosome Deletion , Chromosomes, Human, Pair 2/genetics , Chromosomes, Human, Pair 5/genetics , Fatal Outcome , Female , Humans , Lymphocytes/pathology , Lymphoma, Large-Cell, Anaplastic/genetics , Pregnancy , Translocation, Genetic
8.
Anticancer Res ; 20(5A): 3007-12, 2000.
Article in English | MEDLINE | ID: mdl-11062715

ABSTRACT

Ferric and aluminum complexes with ATP have shown the induction of tumors in the site of subcutaneous injection, whereas sodium ATP has not. A concomitant but apparently independent phenomenon was a severe lymphoadenitis. The tumor calcium concentration showed an inverse relationship with the tumor growth rate. Carcinogenesis and lymphoadenitis are discussed considering well known effects of ferric and aluminum complexes with ATP on the cellular calcium homeostasis and of ATP on lymphatic tissue proliferation.


Subject(s)
Adenocarcinoma/chemically induced , Adenosine Triphosphate/toxicity , Aluminum Compounds/toxicity , Carcinogens/toxicity , Ferric Compounds/toxicity , Skin Neoplasms/chemically induced , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Adenosine Triphosphate/administration & dosage , Adenosine Triphosphate/metabolism , Aluminum Compounds/administration & dosage , Aluminum Compounds/metabolism , Animals , Carcinogenicity Tests , Carcinogens/administration & dosage , Carcinogens/metabolism , Female , Ferric Compounds/administration & dosage , Ferric Compounds/metabolism , Mice , Skin Neoplasms/metabolism , Skin Neoplasms/pathology
9.
Cancer ; 88(7): 1696-702, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10738229

ABSTRACT

BACKGROUND: The prognosis for survival of patients infected with the human immunodeficiency virus (HIV) who develop non-Hodgkin lymphoma (NHL) usually is considered to be poor. To the authors' knowledge the impact of highly active antiretroviral therapy, recently introduced in HIV disease case management, has not yet been studied in such circumstances. METHODS: All cases of NHL prospectively diagnosed between January 1986 and December 1997 among patients followed in the Aquitaine Cohort were reviewed. The Kaplan-Meier method and the proportional hazards model were used for statistical analysis. RESULTS: One hundred one NHL diagnoses were validated during the 12-year study period. The median proportional hazards cell count at the time of diagnosis of NHL was 112/mm(3). Histologic findings (Working Formulation classification) were: intermediate grade (N = 23), high grade (N = 61), other (N = 7), and undetermined (N = 10). In 56% of cases, staging classification was Ann Arbor Stage IV. Approximately 73% of patients received a specific NHL chemotherapy. During follow-up, 44% were treated with nucleoside reverse transcriptase inhibitors (NRTIs) alone and 18% with triple therapy including a protease inhibitor (PI). The median survival was 6.0 months. In multivariate analysis, after adjusting for age, year of NHL diagnosis, histologic type, medical center, and transmission category, the following factors recorded at the time of diagnosis of NHL were indicative of an increasing risk of death: CD4+ count

Subject(s)
HIV Infections/complications , Lymphoma, Non-Hodgkin/diagnosis , Lymphoma, Non-Hodgkin/virology , Adult , Antineoplastic Agents/therapeutic use , Cohort Studies , Disease-Free Survival , Female , HIV Infections/drug therapy , HIV Infections/mortality , HIV Seropositivity/complications , Humans , Lymphoma, Non-Hodgkin/drug therapy , Lymphoma, Non-Hodgkin/mortality , Male , Middle Aged , Prognosis , Protease Inhibitors/therapeutic use , Reverse Transcriptase Inhibitors/therapeutic use , Time Factors
10.
J Am Soc Echocardiogr ; 13(1): 61-3, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10625833

ABSTRACT

We report here a tricky case of right atrial myxoma with a pulmonary localization mimicking pulmonary thromboembolism. The diagnosis on imaging investigation was delayed because of its atypical appearance. This case report emphasizes the leading role of transthoracic and transesophageal echocardiography in the management of this condition. In autopsy series, the incidence of primary tumors of the heart is evaluated at 0.0017% to 0.19%.(1) Nearly half of them are myxoma.(1, 2) Myxoma are more frequently observed in adults and are commonly localized in the left atrium. Signs and symptoms are comparable to those arising in other cardiovascular and systemic conditions, including variable cardiac murmur, uneasiness, blackout, systemic embolism, cardiac insufficiency, lasting fever, or sudden death.(3) Rare cases of pulmonary embolism have been described. We report here an atypical case of right atrial myxoma with a pulmonary localization mimicking pulmonary embolus.


Subject(s)
Heart Neoplasms/diagnostic imaging , Myxoma/diagnostic imaging , Pulmonary Embolism/diagnostic imaging , Adult , Diagnosis, Differential , Echocardiography, Transesophageal , Female , Heart Atria , Humans
11.
Pathol Res Pract ; 195(8): 549-53, 1999.
Article in English | MEDLINE | ID: mdl-10483585

ABSTRACT

NGF receptor (TrkA and p75NGFR) expression was investigated in human thymuses, including normal thymuses, thymic hyperplasias, thymomas and thymic carcinomas. TrkAI but not TrkAII transcripts were demonstrated by RT-PCR. In normal thymuses, immunohistochemistry revealed a restricted TrkA-immunoreactivity to epithelial and interdigitated reticular cells, while only interdigitaded reticular cells were immunoreactive for p75NGFR. Thymocytes were negative for both receptors. A switch from the normal TrkA positive-p75NGFR negative phenotype to a TrkA negative-p75NGFR positive phenotype was found in histologically aggressive epithelial cell tumors, suggesting that NGF and its receptors are potentially involved in thymus stroma organogenesis and proliferation.


Subject(s)
Carcinoma/metabolism , Receptors, Nerve Growth Factor/biosynthesis , Thymoma/metabolism , Thymus Gland/metabolism , Thymus Neoplasms/metabolism , Antigens, Nuclear , Humans , Hyperplasia/metabolism , Immunohistochemistry , Nuclear Proteins/biosynthesis , Protein Isoforms/biosynthesis , Receptor, trkA/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Thymus Gland/pathology
12.
Am J Pathol ; 154(2): 405-15, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10027399

ABSTRACT

The expression of neurotrophins and their receptors, the low-affinity nerve growth factor receptor (p75LNGFR) and the Trk receptors (TrkA, TrkB, and TrkC), was investigated in human bone marrow from 16 weeks fetal age to adulthood. Using reverse transcription-polymerase chain reaction, all transcripts encoding for catalytic and truncated human TrkB or TrkC receptors were detected together with trkAI transcripts, whereas trkAII transcripts were found only in control nerve tissues. Transcripts for the homologue of the rat truncated TrkC(ic113) receptor were identified for the first time in human tissue. Stromal adventitial reticular cells were found immunoreactive for all neutrophin receptors. In contrast, hematopoietic cell types were not immunoreactive for p75LNGFR but showed immunoreactivity for one or several Trk receptors. TrkA immunoreactivity was found in immature erythroblasts. Catalytic TrkB immunoreactivity was observed in eosinophilic metamyelocytes and polymorphonuclear cells. Truncated TrkB immunoreactivity was found in erythroblasts and megacaryocytes. Immunoreactivity for both catalytic and truncated TrkC receptor was observed in promyelocytes, myelocytes, some polymorphonuclear cells and megacaryocytes. Neutrophin transcript levels appeared higher at fetal than at adult stages, no variation in Trk family transcript levels was observed. The local expression of neurotrophin genes suggests a wide range of paracrine and/or autocrine mode of action through their corresponding receptors within the bone marrow.


Subject(s)
Bone Marrow Cells/metabolism , Nerve Growth Factors/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Nerve Growth Factor/metabolism , Adult , Amino Acid Sequence , Animals , Base Sequence , Cell Lineage , DNA Primers/chemistry , Female , Fetus/metabolism , Gestational Age , Humans , Immunoenzyme Techniques , Molecular Sequence Data , Nerve Growth Factors/genetics , Protein Isoforms/genetics , RNA/analysis , Rats , Reverse Transcriptase Polymerase Chain Reaction , Stromal Cells/metabolism
13.
Leuk Lymphoma ; 31(3-4): 423-8, 1998 Oct.
Article in English | MEDLINE | ID: mdl-9869208

ABSTRACT

We report a fatal primary cardiac non-Hodgkin's lymphoma in a 62 years old immunocompetent woman presenting with tamponade and complete atrioventricular block. CT-scan, echocardiography and autopsy examination showed a tumor largely infiltrating the heart without extracardiac involvement. A surgical biopsy revealed high grade B-cell non-Hodgkin's lymphoma with a misleading myelomonocytic CD68 (KPI) expression. Polymerase Chain Reaction analysis revealed a clonal rearrangement of the immunoglobulin heavy chain gene and confirmed the B-cell origin of the lymphoma. Our report also emphasizes the role of immunohistochemical and molecular techniques in the diagnosis.


Subject(s)
Heart Neoplasms/pathology , Heart Neoplasms/physiopathology , Lymphoma, B-Cell/pathology , Lymphoma, B-Cell/physiopathology , Antigens, CD , Antigens, Differentiation, Myelomonocytic , Female , Heart Block/etiology , Heart Block/pathology , Heart Block/physiopathology , Heart Neoplasms/complications , Humans , Lymphoma, B-Cell/complications , Middle Aged
14.
J Neuroimmunol ; 85(1): 11-21, 1998 May 01.
Article in English | MEDLINE | ID: mdl-9626993

ABSTRACT

The expression of NGF receptors was investigated in normal human thymus and in thymic hyperplasias, thymomas and thymic carcinomas. By RT-PCR, we detected TrkAI transcripts encoding for the high-affinity NGF receptor. Western blot analysis showed the presence of both TrkA and p75NGFR proteins. In normal thymuses, epithelial subcapsular and medullar cells were TrkA immunoreactive. Interdigitated medullar cells were stained for both TrkA and p75NGFR. While epithelial cells of normal thymuses or benign thymomas exhibited a TrkA positive-p75NGFR negative phenotype, a switch to a TrkA negative-p75NGFR positive phenotype was observed in malignant epithelial cell tumours and was associated with cell proliferation-associated MIB1 expression. Our results argue for a local role of NGF and its receptors on thymic stromal cells both in normal and neoplastic conditions.


Subject(s)
Carcinoma/metabolism , Receptors, Nerve Growth Factor/metabolism , Thymoma/metabolism , Thymus Gland/metabolism , Thymus Hyperplasia/metabolism , Thymus Neoplasms/metabolism , Adolescent , Adult , Aged , Carcinoma/pathology , Child , Female , Fetus , Humans , Infant , Male , Middle Aged , Nerve Growth Factors/genetics , Proto-Oncogene Proteins/metabolism , RNA, Messenger/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptor, Nerve Growth Factor , Receptor, trkA , Reference Values , Thymoma/pathology , Thymus Gland/cytology , Thymus Gland/pathology , Thymus Hyperplasia/pathology , Thymus Neoplasms/pathology , Tissue Distribution
16.
J Infect ; 35(2): 155-61, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9354350

ABSTRACT

We estimated the incidence of the first episodes of cytomegalovirus (CMV) disease in the Aquitaine cohort of HIV-infected subjects, south-western France. Cases were retrospectively investigated using standardized definition criteria. Retinitis was confirmed by an ophthalmologist. Gastro-intestinal lesions were confirmed histologically. Encephalitis was histologically confirmed; it was considered possible if TDM or magnetic resonance imaging (MRI) and symptomatology suggested this diagnosis. Pneumopathy was probable in case of hypoxemia, interstitial X-Ray images and response to CMV treatment; it was confirmed if intranuclear inclusions were identified on biopsy or brushing specimen. In the cohort (n = 3525) followed for an average of 46 months, 158 patients had a first episode of CMV disease. The cumulative incidence was 4.5% and the incidence rate (IR) 1.2 per 100 person-years. The IR was higher for homosexuals (2.0) than for heterosexuals (1.0) and intravenous drug users (0.5). Retinitis was the most frequent site (90 cases), followed by digestive system (40), lung (three confirmed and 17 probable) and central nervous system (eight confirmed and three possible). Sixty-eight percent of the patients were at the AIDS stage when CMV disease was diagnosed, with a mean CD4 count of 42/mm3. The cumulative probability of developing CMV disease 2 years after falling below 200 CD4 lymphocytes/mm3 was 8.0%. Retinitis is by far the most common site for CMV disease. Homosexual transmission of HIV, clinical AIDS and low CD4 count are associated with the occurrence of the first episode of CMV disease.


Subject(s)
AIDS-Related Opportunistic Infections/epidemiology , Cytomegalovirus Infections/epidemiology , Cytomegalovirus , Adult , Female , France/epidemiology , Humans , Incidence , Male , Retrospective Studies
17.
Mod Pathol ; 10(10): 1015-20, 1997 Oct.
Article in English | MEDLINE | ID: mdl-9346181

ABSTRACT

Splenic lymphoma with villous lymphocytes (SLVL) is a chronic monoclonal B-cell lymphoproliferative disorder characterized by massive splenomegaly and typical villous lymphocytes in the peripheral blood (PB). The diagnosis of SLVL relies on blood smear examination, phenotypic features, and marginal zone involvement of the spleen. The histologic pattern of bone marrow (BM) involvement has not been well characterized. We report four cases associated with a peculiar intrasinusoidal BM involvement. This intrasinusoidal pattern was highlighted by immunostaining that also showed the cytoplasmic projections of villous lymphocytes within routinely fixed and decalcified BM biopsy specimens. Therefore, a simple immunohistochemical analysis of BM involvement would help to identify SLVL. Combined with cytologic and immunophenotypic evaluation of marrow and blood smears, this intravascular pattern might be helpful in differentiating SLVL from hairy cell leukemia and its variant. Whether this peculiar intravascular pattern combined with cytologic evaluation represents a practical alternative to the diagnostic splenectomy must be confirmed by extensive studies focusing on this immunohistochemical criterion.


Subject(s)
B-Lymphocytes/pathology , Bone Marrow/pathology , Lymphoma, B-Cell/pathology , Splenic Neoplasms/pathology , Aged , Aged, 80 and over , Antigens, CD/analysis , Antigens, Neoplasm/analysis , B-Lymphocytes/ultrastructure , Diagnosis, Differential , Female , Humans , Immunohistochemistry , Leukemia, Hairy Cell/diagnosis , Lymphoma, B-Cell/chemistry , Lymphoma, B-Cell/immunology , Male , Middle Aged , Splenic Neoplasms/chemistry , Splenic Neoplasms/immunology
18.
J Neuroimmunol ; 77(2): 161-73, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9258246

ABSTRACT

To identify nerve growth factor (NGF) target cells in normal and pathologic human lymphoid tissues, we have studied the expression of the low-affinity NGF receptor (p75LNGFR) and the high-affinity tropomyosin-related kinase NGF receptor (TrkA). A RNAse protection assay revealed the expression of trk transcripts in thymus, spleen, palatine tonsils and lymph nodes. TrkA immunoreactivity was shown in thymic epithelial cells, cryptic tonsillar epithelium and several monocyte-derived cells including epithelioid and multinucleated Langhans' cells, follicular dendritic cells and interdigitated reticular cells. TrkA immunoreactivity was rarely observed in normal T- and B-lymphocytes, but was intense in lymphoma cells of several B-cell lymphoma subtypes, anaplastic large cell lymphomas and Reed-Sternberg cells. Western blot analysis revealed the presence of p75LNGFR and of p80Trk and glycosylated Trk isoforms (gp110, gp140). p75LNGFR immunoreactivity was detected in epithelial Hassal's bodies, follicular dendritic cells, interdigitated reticular cells, periarteriolar macrophages, endothelial sinusal cells and nerve endings. The broad expression of NGF receptors may be an indicator of neurotrophin activity in lymphoid tissues and suggests their implication in inflammatory or lymphoproliferative disorders.


Subject(s)
Lymphoid Tissue/metabolism , Lymphoid Tissue/pathology , Proto-Oncogene Proteins/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Nerve Growth Factor/metabolism , Antibodies, Monoclonal/chemistry , Antisense Elements (Genetics) , Blotting, Western , Humans , Immunohistochemistry , Lymphoid Tissue/chemistry , Proto-Oncogene Proteins/chemistry , RNA/isolation & purification , RNA Probes , Receptor Protein-Tyrosine Kinases/chemistry , Receptor, trkA , Receptors, Nerve Growth Factor/chemistry , Ribonucleases/genetics , Staining and Labeling
19.
Leuk Lymphoma ; 26(5-6): 615-9, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9389369

ABSTRACT

We present the case of a two-year-old child with an atypical presentation of chronic myeloid leukemia. At diagnosis, he showed clinical and biological features of juvenile chronic myeloid leukemia (CML). However, eosinophilia was observed in blood and bone marrow. The bone marrow karyotype did not demonstrate the Philadelphia chromosome but BCR-ABL rearrangement was shown to be present by reverse transcriptase polymerase chain reaction (RT-PCR) analysis and confirmed by fluorescent in situ hybridization (FISH) analysis. Discussion centres on the differentiation between juvenile CML and childhood chronic myelogenous Leukemia and the importance of carrying out RT PCR for all juvenile CML cases.


Subject(s)
Fusion Proteins, bcr-abl/genetics , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/diagnosis , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics , Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative/diagnosis , Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative/genetics , Child, Preschool , Diagnosis, Differential , Gene Rearrangement , Humans , Karyotyping , Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology , Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative/pathology , Male
20.
Histopathology ; 31(1): 83-6, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9253629

ABSTRACT

AIMS: We present the clinical and histopathological findings of an unusual pulmonary cystic lymphoepithelial lesion in an HIV sero-positive patient. METHODS AND RESULTS: The 32-year-old female patient developed two nodules in the vicinity of the right and left hila. Left upper lobectomy showed a 40-mm wide cystic lesion. The cyst wall was lined by a squamous epithelium and lymphoid tissue with a marked follicular hyperplasia and a prominent follicular cell dendritic network expressing HIV major core protein p24. CONCLUSIONS: The absence of an Epstein-Barr virus infected lymphoid population and monoclonal immunoglobulin gene rearrangement supported the benign nature of the lesion.


Subject(s)
HIV-1/isolation & purification , Lung Diseases/pathology , Lymphocele/pathology , Lymphoid Tissue/pathology , Adult , Epithelium/pathology , Epithelium/virology , Female , HIV Core Protein p24/analysis , Humans , Lung Diseases/virology , Lymphocele/virology , Lymphoid Tissue/virology
SELECTION OF CITATIONS
SEARCH DETAIL